Back
Pacific Biosciences of California Vs. Simulations Plus Industry Stock Comparison
Buy
74
PACB
Pacific Biosciences of California
Last Price:
1.73
Seasonality Move:
23.69%
Sell
30
SLP
Simulations Plus
Last Price:
30.22
Seasonality Move:
4.76%
Buy
74
Pacific Biosciences of California (PACB)
is a Buy
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.72. The Score for PACB is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- PACB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $30.22. The Score for SLP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PACB is experiencing slight buying pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $30.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 51.8 | Buy |
Chaikin Money Flow: | 1685201 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.5 - 1.86) | Buy |
Bollinger Bands (100): | (1.44 - 1.94) | Buy |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.31 | Sell |
Relative Strength Index (14 RSI): | 30.89 | Sell |
Chaikin Money Flow: | -69284 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.76 - 33.9) | Sell |
Bollinger Bands (100): | (33.91 - 46.71) | Sell |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.67 | Buy |
20-day SMA: | 1.75 | Sell |
50-day SMA: | 1.66 | Buy |
200-day SMA: | 3.38 | Sell |
8-day EMA: | 1.69 | Buy |
20-day EMA: | 1.69 | Buy |
50-day EMA: | 1.69 | Buy |
200-day EMA: | 3.39 | Sell |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.96 | Sell |
20-day SMA: | 31.69 | Sell |
50-day SMA: | 34.89 | Sell |
200-day SMA: | 41.59 | Sell |
8-day EMA: | 30.92 | Sell |
20-day EMA: | 31.96 | Sell |
50-day EMA: | 34.8 | Sell |
200-day EMA: | 40.17 | Sell |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.22 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.
Pacific Biosciences of California Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |